World-Class Speaker Faculty
Speakers
Alejandro Rangel
Applied Neurosciences Department Head
Mexican Council of Neuroscience
Day One
Tuesday, April 19, 2022
11:45 am | Narrowing the Gap to Diagnose Alzheimer’s Disease Through Biomarkers
Andrea Crotti
Associate Director
Arrakis Therapeutics
Day Two
Wednesday, April 20, 2022
12:00 pm | Microglial Emerging Therapies & Targets under Clinical Trial for Neurodegenerative & Neuropsychiatric Disorders
10:00 am | Panel Discussion: Targets for Neuroinflammation
Andrew Koemeter-Cox
Associate Director
The Michael J Fox Foundation for Parkinson’s Disease
Day One
Tuesday, April 19, 2022
11:15 am | Inflammation Biomarkers for Parkinson's Disease & Fox Foundation Resources
Brenda Moore
Research Assistant Professor
University of Florida
Day One
Tuesday, April 19, 2022
3:00 pm | Immunomodulation of Tau Pathology in Organotypic Brain Slice Cultures
Christopher Barnum
Head of Neuroscience
Inmune Bio
Day One
Tuesday, April 19, 2022
4:30 pm | Approaching Clinical Trials Targeting the Immune System: Understanding Biomarker Selection & Treatment Responses
Dimitry Ofengeim
Head of Precision Neurology & Neuroinflammation
Sanofi Genzyme
Day Two
Wednesday, April 20, 2022
1:30 pm | Analyzing the Role of Microglia in Neuroinflammatory Responses in MS: Insights from BTK
Dong Seok Kim
Chief Executive Officer
Aevis Bio
Pre-Conference Workshop Day
Monday, April 18, 2022
4:00 pm | Workshop D: Delving into the Role of Neuroinflammation in Traumatic Brain Injury (TBI)
Francisco Javier Quintana
Professor of Neurology; Associate Member
Ann Romney Centre for Neurologic Diseases Brigham & Women’s Hospital; Harvard Medicine School; The Broad Institute
Day Two
Wednesday, April 20, 2022
2:00 pm | Astrocytes as Therapeutic Targets in Neurologic Diseases
Hung-Kai (Kevin) Chen
Chairman & Chief Executive Officer
Elixiron Immunotherapeutics
Day Two
Wednesday, April 20, 2022
9:30 am | Utilizing Small Molecular Inhibitors to Target & Reduce Neuroinflammation
Jennifer Barnett
Chief Executive Officer
Monument Therapeutics
Day One
Tuesday, April 19, 2022
9:30 am | Using Digital Biomarkers to Apply a Stratified Approach to Neuroinflammation
Jesse Cedarbaum
Acting Chief Medical Officer
ImmunoBrain Checkpoint
Day One
Tuesday, April 19, 2022
4:00 pm | Therapeutics for Neurodegenerative Disease – Cutting All 3 Legs
9:00 am | Opening Panel Discussion: What’s New in Neuroimmunology Drug Development?
Johan Luthman
Executive Vice President & Head of R&D
Lundbeck A/S
Day Two
Wednesday, April 20, 2022
10:00 am | Panel Discussion: Targets for Neuroinflammation
8:30 am | Using Classic Neuroimmunological Targets & Applying them to Different Neuroimmunology Indications
Johannes Grosse
Senior Director of Drug Discovery
Vir Biotechnology
Pre-Conference Workshop Day
Monday, April 18, 2022
1:30 pm | Workshop C: Examining the Role of Genetics in Neuroinflammation & Neurodegenerative Disease
Julie Huang
Senior Scientist, Biomarker Sciences
Alector
Day One
Tuesday, April 19, 2022
12:15 pm | Utilizing Inflammatory Biomarkers to Assess the Activity of a Novel Therapeutic in Frontotemporal Dementia Patients with Granulin Mutation
Kuti Baruch
Head of R&D
ImmunoBrain Checkpoint
Day Two
Wednesday, April 20, 2022
11:30 am | Targeting the Peripheral Immune System as a Novel Therapeutic Approach in Alzheimer’s Disease
10:00 am | Panel Discussion: Targets for Neuroinflammation
Lindsay De Biase
Assistant Professor
University of California Los Angeles
Pre-Conference Workshop Day
Monday, April 18, 2022
4:00 pm | Workshop D: Delving into the Role of Neuroinflammation in Traumatic Brain Injury (TBI)
LuLin Jiang
Staff Scientist
Sanford Burnham Prebys Medical Discovery Institute
Day Two
Wednesday, April 20, 2022
3:00 pm | The Role of Astrocytic Protein Homeostasis in Regulating Neuroinflammation & Neurodegeneration in AD
Malu Tansey
Professor of Neuroscience & Neurology; Co-Director
University of Florida College of Medicine; Centre for Translational Research in Neurodegenerative Disease
Day One
Tuesday, April 19, 2022
1:45 pm | Using Preclinical Models to Inform Clinical Trial Design Targeting Chronic Inflammation in Neurodegenerative Disease
9:00 am | Opening Panel Discussion: What’s New in Neuroimmunology Drug Development?
Marianthi Papakosta
Head of In Vitro Neuroinflammation Pharmacology, Cell Protection Unit & Neuroscience
Takeda Pharmaceuticals
Day One
Tuesday, April 19, 2022
2:30 pm | Analyzing In Vitro Models of Microglia in Relation to Inflammasomes
9:00 am | Opening Panel Discussion: What’s New in Neuroimmunology Drug Development?
Marie-Kim St-Pierre
PhD Candidate
University of Victoria
Day Two
Wednesday, April 20, 2022
3:30 pm | Dark Astrocytes are Characterized By their State of Cellular & Metabolic Stress In Contexts of Neurodegeneration
Mark Kiel, MD, PhD
Chief Scientific Officer
Genomenon
Mark Treherne
Chairman
Talisman Therapeutics
Day Two
Wednesday, April 20, 2022
9:00 am | The Pivotal Role of Glia in Neuroinflammation
Massimiliano Bianchi
Founder, President & Chief Executive Officer
Ulysses Neuroscience
Day One
Tuesday, April 19, 2022
2:15 pm | Translational Models of Neuroinflammation: An Update from Ulysses Neuroscience on Depression, Rare Diseases & Parkinson’s Disease
Michael Mingueneau
Director of Research
Biogen
Day Two
Wednesday, April 20, 2022
11:00 am | Leveraging Well-Understood Peripheral Immune Targets to Advance our Understanding of Microglial Biology in the CNS
10:00 am | Panel Discussion: Targets for Neuroinflammation
Mike Nagle
Senior Director, Head of Neurogenomics
Eisai
Pre-Conference Workshop Day
Monday, April 18, 2022
1:30 pm | Workshop C: Examining the Role of Genetics in Neuroinflammation & Neurodegenerative Disease
Nigel Greig
Chief, Drug Design & Development Section
National Institute on Aging, NIH
Pre-Conference Workshop Day
Monday, April 18, 2022
4:00 pm | Workshop D: Delving into the Role of Neuroinflammation in Traumatic Brain Injury (TBI)
Nikhil Sharma
Founder & Chief Executive Officer
BioCortex
Pre-Conference Workshop Day
Monday, April 18, 2022
11:00 am | Workshop B: Exploring the Role of the Gut-Brain Axis in Neuroinflammation
Olivia Corradin
Assistant Professor of Biology
MIT
Pre-Conference Workshop Day
Monday, April 18, 2022
1:30 pm | Workshop C: Examining the Role of Genetics in Neuroinflammation & Neurodegenerative Disease
Paul Ashton
Chief Executive Officer & President
Inflammasome Therapeutics
Richard Wyse
Director of R&D
The Cure Parkinson’s Trust
Day One
Tuesday, April 19, 2022
8:50 am | Chair’s Opening Remarks
Stan Chamberlain
Chief Scientific Officer
T3D Therapeutics
Stanley Appel
Co-Director
Houston Methodist Neurological Institute; Advisory Board Chair COYA Therapeutics
Day One
Tuesday, April 19, 2022
5:00 pm | Suppressing Neuroinflammation: T-REG Cell Therapy of ALS
9:00 am | Opening Panel Discussion: What’s New in Neuroimmunology Drug Development?
Thomas Nieland
Director & Head of Target Validation & Exploratory Biology
Verge Genomics
Pre-Conference Workshop Day
Monday, April 18, 2022
8:30 am | Workshop A: Deep-Dive into the Use of iPSC-Derived Cells Models to Measure Neuroinflammation in Neurodegeneration
Yung-Chih (Inge) Cheng
Principal Scientist
Pfizer
Pre-Conference Workshop Day
Monday, April 18, 2022